Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE\NAPROXEN Cause Rebound acid hypersecretion? 9 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Rebound acid hypersecretion have been filed in association with ESOMEPRAZOLE\NAPROXEN. This represents 0.2% of all adverse event reports for ESOMEPRAZOLE\NAPROXEN.

9
Reports of Rebound acid hypersecretion with ESOMEPRAZOLE\NAPROXEN
0.2%
of all ESOMEPRAZOLE\NAPROXEN reports
4
Deaths
0
Hospitalizations

How Dangerous Is Rebound acid hypersecretion From ESOMEPRAZOLE\NAPROXEN?

Of the 9 reports, 4 (44.4%) resulted in death.

Is Rebound acid hypersecretion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE\NAPROXEN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE\NAPROXEN Cause?

Chronic kidney disease (2,714) Renal failure (2,374) Acute kidney injury (1,120) Death (705) Drug ineffective (459) Off label use (440) Nausea (431) End stage renal disease (349) Tubulointerstitial nephritis (315) Hyperhidrosis (308)

What Other Drugs Cause Rebound acid hypersecretion?

ESOMEPRAZOLE (2,501) OMEPRAZOLE (2,350) LANSOPRAZOLE (1,713) PANTOPRAZOLE (1,581) DEXLANSOPRAZOLE (1,160) OMEPRAZOLE\SODIUM BICARBONATE (95) RABEPRAZOLE (64) RANITIDINE (29) FAMOTIDINE (12)

Which ESOMEPRAZOLE\NAPROXEN Alternatives Have Lower Rebound acid hypersecretion Risk?

ESOMEPRAZOLE\NAPROXEN vs ESTAZOLAM ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL CYPIONATE ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\LEVONORGESTREL ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\NORETHINDRONE

Related Pages

ESOMEPRAZOLE\NAPROXEN Full Profile All Rebound acid hypersecretion Reports All Drugs Causing Rebound acid hypersecretion ESOMEPRAZOLE\NAPROXEN Demographics